Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully explore the l